W-7; hydrochlorure

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Reversible: yes

Product does not compete with ATP.

Primary TargetMyosin light chain kinase

Target IC₅₀: 51 µM inhibiting myosin light chain kinase; 28 µM inhibiting Ca2+-calmodulin-dependent phosphodiesterase

Cell permeable: yes

General description

A cell-permeable and reversible calmodulin antagonist that inhibits myosin light chain kinase (IC₅₀ = 51 µM) and Ca²⁺-calmodulin-dependent phosphodiesterase (IC₅₀ = 28 µM).

A cell-permeable and reversible calmodulin antagonist that inhibits Ca²⁺-calmodulin-dependent phosphodiesterase (IC₅₀ = 28 µM) and myosin light chain kinase (IC₅₀ = 51 µM).

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Caulfield, M.P., et al. 1991. Neurosci. Lett.125, 57.Asano, M. 1989. J. Pharmacol. Exp. Ther.251, 764.Itoh, H., and Hidaka, H. 1984. J. Biochem.96, 1721.Tanaka, T., et al. 1983. Pharmacol.26, 249.Hidaka, H. 1981. Proc. Natl. Acad. Sci. USA 78, 4354.

Packaging

10 mg in Plastic ampoule

Warning

Toxicity: Standard Handling (A)